The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
August 28th 2025
An immunomodulatory nanoparticle called Agg-CLNP has been shown to effectively prevent disease onset for rheumatoid arthritis (RA).
Pledging Support: Growing Up at a Healthy Weight Requires a National Movement
February 5th 2015The Robert Wood Johnson Foundation today announced it will commit $500 million over the next ten years to expand efforts to ensure that all children in the United States-no matter who they are or where they live-can grow up at a healthy weight.
Read More
Health Care Groups Identify Potential Measures to Address Ongoing Drug Shortages
February 5th 2015As shortages of lifesaving medicines, including antibiotics, chemotherapy, and cardiovascular drugs continue to plague the United States, a group of health care organizations released a report exploring measures that should be considered to address this ongoing issue.
Read More
Avella Selected by GlaxoSmithKline to Retain Access to Benlysta
February 5th 2015Avella Specialty Pharmacy announced today that it has been selected by GlaxoSmithKline as one of a select group of pharmacies authorized to continue to distribute Benlysta, a medication approved by the FDA for the treatment of systemic lupus erythematosus in patients who have previously received other therapies.
Read More
Outgoing FDA Commissioner's Compounding Pharmacy Impact
February 5th 2015The news of Margaret A. Hamburg, MD, resigning from her long-standing post as FDA Commissioner stirred memories of her success with improving access to emergency contraception, but more so her struggles with regulating drug compounding following a deadly fungal meningitis outbreak traced to a compounding pharmacy's tainted drugs.
Read More
Pharmacists' Heart Risks Worsening Despite Health Expertise
February 5th 2015Despite having adequate knowledge on cardiovascular risk factors, pharmacists and other health care professionals showed significant increases in systemic arterial hypertension and excessive weight gain across a 20-year study.
Read More
Pfizer and Hospira today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Hospira, the world's leading provider of injectable drugs and infusion technologies and a global leader in biosimilars, for $90 a share in cash for a total enterprise value of approximately $17 billion.
Read More
Exploring and Defining the Community Pharmacists' Role in HIV Prevention, Testing and Care
February 4th 2015The roles that community pharmacists play in human immunodeficiency virus prevention, testing and care are explored in several research and experience articles in the Journal of the American Pharmacists Association. The four articles discuss community pharmacists' roles and pharmacists' perceptions of their patient care services among people living with HIV.
Read More
When to Educate Epilepsy Patients, Caregivers about Sudden Death Risk
February 4th 2015Even though most patients and their caregivers want to know about sudden unexpected death in epilepsy (SUDEP), if and when health care professionals should provide related information remains up in the air.
Read More
Combining Baclofen with Omeprazole May Further Reduce GERD Symptoms
February 4th 2015A recent study suggests that co-administering the muscle relaxant, baclofen, with the proton pump inhibitor (PPI), omeprazole, may be more effective than PPI monotherapy in reducing heartburn and regurgitation in patients with gastroesophageal reflux disease (GERD).
Read More
Hospira Recalls One Lot of Sodium Chloride Injection Due to Particulate Matter
February 4th 2015Hospira, Inc, of Lake Forest, IL, has announced a voluntary nationwide recall of one lot of 0.9% Sodium Chloride Injection, USP, 250 mL (NDC 0409-7983-02, expiration August 1) due to the presence of particulate matter.
Read More
Rogue Internet Drug Seller Activity Highlights Need for .Pharmacy Domain Public Health Initiative
February 4th 2015NABP has issued a report underscoring the need for the .Pharmacy Top-Level Domain Program as a public health initiative to help consumers distinguish legitimate online pharmacies from rogue online drug sellers.
Read More